Fresenius Kabi intros Kinevac authorized generic

Fresenius Kabi is offering Sincalide for injection, an authorized generic for Bracco Diagnostics’ Kinevac (Sincalide for injection).

The new product broadens Fresenius Kabi’s radiology portfolio and is available immediately in the United States.

Sincalide for injection is a diagnostic aid used to help diagnose certain problems of the gallbladder and pancreas. It also is used to speed up the transit of a barium meal, a contrast agent, given in preparation for an X-ray examination of the intestines.

[Read more: Fresenius Kabi intros generic Foscavir]

"Fresenius Kabi is pleased to introduce Sincalide for injection in the United States as our newest first-to-market authorized generic, demonstrating our commitment to supporting the radiology community and strengthening the U.S. supply chain of care," said John Ducker, president and CEO of Fresenius Kabi USA. "Diagnostic pharmaceutical agents like Sincalide play a critical role in patient diagnosis, and Fresenius Kabi's addition of Sincalide provides healthcare facilities nationwide with new options to ensure timely patient care."

[Read more: Fresenius Kabi intros generic Alimta]

Sincalide for injection is available in 5 mcg single-dose vials. The medication is preservative-free, and the container closure is not made with natural rubber latex, the company said.